UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Medipost hits record vial sales for Cartistem
Medipost said Thursday that it hit record sales of 266 vials for Cartistem,...
by Lee Han-soo
|
2017-11-30 16:16
라인
Biopharmaceutical firms' liver treatments draw attention
Local biopharmaceutical companies, including Sillajen, HLB, and Pharmicell,...
by So Jae-hyeon
|
2017-11-30 12:02
라인
What are doctors’ views on Invossa used even by foreign patients?
An increasing number of patients here are trying to obtain Invossa-K, an os...
by Lee Hye-seon
|
2017-11-29 09:31
라인
Green Cross, Feldan start joint tech development
Green Cross Labcell and Feldan Therapeutics, a Canadian biotechnology compa...
by Lee Han-soo
|
2017-11-27 16:59
라인
Foreigners dump Medytox, Hugel; buy Celltrion, ViroMed
On Korea’s secondary stock market, foreign investors net bought the shares ...
by Nam Doo-hyun
|
2017-11-27 13:13
라인
Biogen Korea taps new CEO
Biogen Korea, the Korean branch of the American multinational biotech Bioge...
by Marian Chu
|
2017-11-27 11:57
라인
Clinical trials on CAR-T cell therapies surge in two years
The number of clinical trials on CAR-T (chimeric antigen receptor T-cell) t...
by Nam Doo-hyun
|
2017-11-24 15:53
라인
Kolon okayed for clinical trial to expand treatment for Invossa-K injection
The Ministry of Food and Drug Safety (MFDS) has approved Kolon Life Science...
by Lee Han-soo
|
2017-11-23 15:53
라인
GemVax & KAEL confirms potential tracer effective to reperfusion injury
A study conducted by the Seoul National University has confirmed that GV100...
by Constance Williams
|
2017-11-22 15:51
라인
COGIB spotlights future of innovative biotherapeutic
The Coordinating Center for Global Innovative Biotherapeutics (COGIB) analy...
by Lee Han-soo
|
2017-11-22 11:06
라인
KAEL confirms potential tracer as treatment for kidney cancer
GemVax & KAEL said a research article that confirms the potential of GV1001...
by Constance Williams
|
2017-11-20 15:44
라인
Samsung Bioepis wins European sales approval for Ontruzant
The European Commission (EC) has granted marketing authorization for Samsun...
by Lee Han-soo
|
2017-11-20 10:48
라인
ViroMed aims phase 1 trial on CAR-T cell therapy by 2020-2022
ViroMed said it would conduct a phase 1 clinical trial on CAR-T (chimeric a...
by Nam Doo-hyun
|
2017-11-17 13:53
라인
Earthquake hits biopharmaceutical factories in Pohang
With a magnitude 5.4 quake hitting Pohang in North Gyeongsang Province, ind...
by Nam Doo-hyun
|
2017-11-16 15:55
라인
J&J struggles to maintain market dominance of Remicade
Johnson & Johnson's (J&J) is going all out to maintain the dominance of...
by Lee Han-soo and Nam Doo-hyun
|
2017-11-16 10:25
라인
Hugel merges with subsidiaries
Hugel said Wednesday that it would merge with its subsidiaries, Hugel Pharm...
by Lee Han-soo
|
2017-11-15 17:51
라인
Macrogen reaffirms diagnostic sequencing capability with CAP certification
Macrogen, a local biotechnology company, announced Wednesday that it has ac...
by Constance Williams
|
2017-11-15 14:48
라인
Janssen drops suit against Samsung Bioepis on Renflexis
Samsung Bioepis said Tuesday that Janssen, a pharmaceutical company of John...
by Lee Han-soo
|
2017-11-14 17:59
라인
Celltrion to test combo therapy of new flu antibody drug, Tamiflu
Celltrion said it plans to launch a clinical trial on a combination therapy...
by Lee Hye-seon
|
2017-11-14 11:38
라인
Biopharmaceutical firms rank high in Kosdaq market cap
Biopharmaceutical firms are showing strong performance on South Korea’s tec...
by Nam Doo-hyun
|
2017-11-13 15:25
-
이전
21
22
23
24
25
26
27
28
29
30
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top